Martin Shkreli, the absolute twat, who bought the patent to a life-saving HIV medicine and then increased the price from $13.50 (less than nine quid) to $750 (nearly £500) a go, is still being a cunt.
In September, the 32-year-old CEO of Turing Pharmaceuticals, pissed off the whole world, when he bought the rights to manufacture Daraprim, which is used to treat people with weak immune systems such as HIV and cancer patients.
After initially arguing with everyone and anyone who criticised the decision, Shkreli backed down, and announced that the price increase wouldn’t go ahead, but refused to say what the new price would be.
Well the bastards not been completely honest.
The Associated Press reports that Turing is reducing charges for hospitals by up to 50 per cent, but medical insurers will still be stuck with most of the $750 per pill tab, which will inevitably drive up future treatment and insurance costs.
Thankfully Imprimis, a pharmacy in San Diego, said it plans to make a generic version of Daraprim for less than a dollar a pill.
More of a concept than a journalist, Tom Percival was forged in the bowels of Salford University from which he emerged grasping a Masters in journalism.
Since then his rise has been described by himself as ‘meteoric’ rising to the esteemed rank of Social Editor at UNILAD as well as working at the BBC, Manchester Evening News, and ITV.
He credits his success to three core techniques, name repetition, personality mirroring, and never breaking off a handshake.